Pharmaceutical solutions & Specialty ingredients

About SEQENS group

Our main activities

A leader in
Pharmaceutical synthesis

Discover

A strong expertise in
Specialty Ingredients

Discover

A complete and integrated
R&D offer

Discover

Committed to developing
and sustainably producing

Discover

Newsroom

#Live

SD-CSR

The French Business Climate Pledge

The hundred French companies involved in the French Business Climate Pledge have raised, between 2016 and 2020, more than €320 billion in funding for…
Read more See all news
General / Protéus

CPhI Webinar series : Enzymes & Biocatalysis for Green Chemistry

On April 28th, during the Webinar Series « Green chemistry : Inspiring sustainable drug manufacturing » organized by CPhI, Julien Boutet, Innovation Manager at Seqens, presented Seqens and Protéus by Seqens approach on « Enzymes & Biocatalysis for Green Chemistry ».
Read more See all news
General / Press Release

Seqens details its investment plan for the production of essential molecules in France

On the occasion of the visit of Mrs Agnès Pannier-Runacher, Minister of Industry, to the Roussillon platform (38), SEQENS details its investment plan…
Read more See all news

#Jobs

See all our offers

Seqens global presence

Use interactive map
0

Employees

0

Scientists, experts and engineers

0

Manufacturing sites

0

Customers in more than 80 countries